Bayer (BAYRY) has entered into an exclusive licensing agreement with Dewpoint Therapeutics for a heart disease program to treat dilated cardiomyopathy patients, who are characterized through ...
Bayer has entered into an exclusive licensing agreement with Dewpoint Therapeutics, Inc. for a heart disease programme to treat dilated cardiomyopathy (DCM) patients, who are characterized through ...
This is the first option exercise under the research collaboration between Bayer and Dewpoint Therapeutics, Inc., which began in November 2019.It leverages Dewpoint’s proprietary platform for ...
Dewpoint Therapeutics, a US biotech focused on the application of biomolecular condensate biology, has announced the nomination of its first development candidate, DPTX3186. This orally-administered ...
The soda is out of the can as Mountain Dew unveiled the mystery flavor for its popular VooDew drink on Halloween. The soft drink brand, produced and owned by PepsiCo, said the "mystery treat ...
BOSTON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc., the leading biotechnology company that develops therapeutics by targeting biomolecular condensates, announced today the nomination ...
Please verify your email address. The latest Mountain Dew promotion brings back Game Fuel's Citrus Cherry flavor alongside a new Citrus Blackberry, each celebrating World of Warcraft’s 20th ...
Mountain Dew is dropping the "MTN" abbreviation it took on in 2009 and bringing back the full "Mountain" to the brand name. PepsiCo They’re dewing it again. Mountain Dew revealed their “new ...
They’re dewing it again. Mountain Dew revealed their “new visual identity” on Tuesday — including dropping the “MTN” abbreviation it took on in 2009 and bringing back the full ...
NEW YORK — "Mtn Dew" is getting a makeover, with the word "mountain" reappearing on cans and bottles following a roughly two-decade-long hiatus. The PepsiCo-owned beverage unveiled a new logo ...
Berlin: Bayer has signed an exclusive licensing agreement with Dewpoint Therapeutics, Inc. for a heart disease program targeting patients with dilated cardiomyopathy (DCM) who have specific genetic ...